.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021260

« Back to Dashboard
NDA 021260 describes AVINZA, which is a drug marketed by King Pharms Llc and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and two Paragraph IV challenges. Additional details are available on the AVINZA profile page.

The generic ingredient in AVINZA is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for NDA: 021260

Tradename:
AVINZA
Applicant:
King Pharms Llc
Ingredient:
morphine sulfate
Patents:1
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 021260

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 021260

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL 021260 NDA STAT RX USA LLC 16590-593 16590-593-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-593-30)
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL 021260 NDA STAT RX USA LLC 16590-593 16590-593-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-593-60)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength30MG
Approval Date:Mar 20, 2002TE:RLD:No
Patent:6,066,339Patent Expiration:Nov 25, 2017Product Flag?YSubstance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength60MG
Approval Date:Mar 20, 2002TE:RLD:No
Patent:6,066,339Patent Expiration:Nov 25, 2017Product Flag?YSubstance Flag?Delist Request?

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength90MG
Approval Date:Mar 20, 2002TE:RLD:No
Patent:6,066,339Patent Expiration:Nov 25, 2017Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc